grace_choung Profile Banner
Grace Choung, MD 박영이 Profile
Grace Choung, MD 박영이

@grace_choung

Followers
757
Following
6K
Media
92
Statuses
2K

Renal pathologist @CedarsSinai #renalpath #kidneydisease opinions are my own https://t.co/vkOgdAdxu8

Los Angeles, CA
Joined April 2010
Don't wanna be here? Send us removal request.
@Rheumat_Aravind
Aravind Palraj
2 days
Blocking TNF doesn’t always suppress immunity. Sometimes it redirects it. Psoriasis. Lupus-like syndrome. Uveitis. Same drug. Opposite immune effects. #Rheumatology #Biologics @DrAkhilX @IhabFathiSulima @drkeithsiau @Drkhenaizan @ArunInamadar #Autoimmune #MedicalEducation
@Rheumat_Aravind
Aravind Palraj
24 days
🔥 TNF-α inhibitors have quietly revolutionised rheumatology. From crippling pain to remission-level control - in RA, PsA, AS, JIA, IBD and more. The immunology is elegant. The outcomes are real. The future is biosimilars + wider access. #Rheumatology #MedTwitter #Immunology
1
35
114
@ziad_zaatari
Ziad El-Zaatari
3 days
🔬 Can you make the diagnosis at 2x...? Incidental Renal Nodule (found at the time of autopsy). #GUpath #Pathology #Kidney #RenalPath #PathResidents
6
14
59
@IzabelaZakrocka
Izabela Zakrocka
2 days
When patient is improving but you’re still not sure what’s going on 🤷‍♀️ thanks for a great case and excellent discussion✨@NephRodby @TWhittier_RUSH @Proximal_Baxi @BajinderR @Rush_Nephrology
1
8
14
@edgarvlermamd
Edgar V. Lerma 🇵🇭
2 days
Obesity‑related glomerulopathy, A growing kidney burden in the obesity pandemic ca. 2025 from @CenJournal @JZRenalPath @Koubar_Sahar @rahaai @SaynaNorouzi #Nephpearls 👉 https://t.co/49KIwt5Tni
@edgarvlermamd
Edgar V. Lerma 🇵🇭
5 months
Kidney Health Guidance on the Management of Obesity in Persons Living with Kidney Diseases ca. 2024 from @asnpublications #Nephpearls 👉 https://t.co/vxPHDSy2H5
0
33
82
@GlomCon
GlomCon
2 days
Check out 👉 Glomerular Disease in Kidney Transplant at https://t.co/S5Vy4yxXvI Post-transplant glomerular diseases represent the third leading cause of kidney graft loss following transplantation. These conditions include recurrence of the original native kidney disease in the
0
5
11
@KIReports
KIReports
3 days
1
12
34
@NDTsocial
NDT
2 days
Biology of drug-induced acute nephrotoxicity: focus on the tubulointerstitium https://t.co/6KTmGwGpRC
0
40
138
@KIReports
KIReports
2 days
Characterizing the #NIH #Activity and #Chronicity Indices in 2 Independent #LupusNephritis Cohorts #VisualAbstract by @deniise_am https://t.co/Qc3B7fqJio
1
4
17
@Ped_Neph
Pediatric Nephrology
2 days
C3 glomerulopathy (C3G) & immune complex-mediated membranoproliferative glomerulonephritis are on a spectrum of glomerular disease. Read this Original Article on pegcetacoplan for idiopathic & familial pediatric C3G. #OpenAccess https://t.co/OdyY6gnEhA
1
9
20
@Renalpathsoc
Renal Pathology Society
4 days
Save the date October 5-9, 2026 for the Joint Banff Foundation for Transplant Pathology and Alberta Transplant Institute Meeting in Banff, Alberta, Canada. More details to come! #renalpath #transplant
0
7
16
@AJKDonline
AJKD
4 days
Response to Rituximab as a Maintenance Therapy in Adult Idiopathic Nephrotic Syndrome: A French Multicenter Cohort Study https://t.co/Og5NbkRKKt @BenoitBrilland @AntoineTHIERR21 @c_massoumipour
1
10
22
@ziad_zaatari
Ziad El-Zaatari
4 days
🔬📸 The Beauty of Immunofluorescence Microscopy! A PLA2R positive glomerulus in a case of primary membraneous glomerulonephritis ~ #Pathology #RenalPath #Kidney #Microscopy #Photomicrography #PathArt
0
11
37
@Renalpathsoc
Renal Pathology Society
5 days
Spectrum of Transplant Rejection: Towards the Implementation of Activity and Chronicity Indices Recording now available Video on-demand link https://t.co/oxIPeVDKcB #renalpath #transplant
1
20
48
@RheumattDoc
Ravi Kumar
5 days
🧠 2022 ACR/EULAR Classification Criteria of ANCA-Associated Vasculitis 📌 Apply only after diagnosing small-/medium-vessel vasculitis 🚫 Exclude mimics before scoring 🟡 Granulomatosis with Polyangiitis (GPA) 🩺 Clinical Criteria •👃🩸 Nasal involvement (bloody discharge,
1
28
70
@hjanders_hans
Hans-Joachim Anders
6 days
Happy to share our new Nat Rev Dis Primer on Podocytopathies @DiseasePrimers including all most recent innovations that impact on management such as anti-nephrin antibodies, ... @PRomagnani @Tobias_B_Huber @AstridWeins @sydney_tang https://t.co/E6X3sReqYH
3
47
86
@PRomagnani
Paola Romagnani
5 days
In Podocytopathies, histology labels lesions—etiology dictates therapy. Time for an etiology-based classification. Our new review just out in Nat Rev Dis Primers: https://t.co/gssv3zBYOJ #Nephrology #PrecisionMedicine #KidneyDisease
3
84
218
@ziad_zaatari
Ziad El-Zaatari
9 days
🔬📷 Glomerulus ~ Jones Silver Stain ~ #Pathology #Histology #RenalPath #Kidney #PathArt
0
12
40
@Zhou1217001
Wenyan Zhou
10 days
#askrenalpath F, SCr increased from 0.8 to 4.3, proteinuria 3g/d, treating lung cancer with anti-VEGF, osimertinib, diphosphonate for several years. Recently adding heparin, diuretic. Microaneurysm(related to antiVEGF) and unique myelin bodies was seen.gene test-. Which drug?
1
8
22
@grace_choung
Grace Choung, MD 박영이
10 days
Continuous indices to assess the phenotypic spectrum of kidney transplant rejection (Nat Commun. 2025 Nov 26;16:10417.) https://t.co/iqeF5HWkcg #transplant #renalpath @Renalpathsoc
0
3
11